BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 22393536)

  • 1. Connecting type 1 and type 2 diabetes through innate immunity.
    Odegaard JI; Chawla A
    Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a007724. PubMed ID: 22393536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance.
    Ballak DB; Stienstra R; Tack CJ; Dinarello CA; van Diepen JA
    Cytokine; 2015 Oct; 75(2):280-90. PubMed ID: 26194067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive immunity in obesity and insulin resistance.
    Sell H; Habich C; Eckel J
    Nat Rev Endocrinol; 2012 Dec; 8(12):709-16. PubMed ID: 22847239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages, immunity, and metabolic disease.
    McNelis JC; Olefsky JM
    Immunity; 2014 Jul; 41(1):36-48. PubMed ID: 25035952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation, cytokines and insulin resistance: a clinical perspective.
    Wieser V; Moschen AR; Tilg H
    Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):119-25. PubMed ID: 23307037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue.
    Harford KA; Reynolds CM; McGillicuddy FC; Roche HM
    Proc Nutr Soc; 2011 Nov; 70(4):408-17. PubMed ID: 21835098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of metabolism by the innate immune system.
    Lackey DE; Olefsky JM
    Nat Rev Endocrinol; 2016 Jan; 12(1):15-28. PubMed ID: 26553134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue inflammation: feeding the development of type 2 diabetes mellitus.
    Richardson VR; Smith KA; Carter AM
    Immunobiology; 2013 Dec; 218(12):1497-504. PubMed ID: 23816302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of inflammatory cytokines in diabetes and its complications.
    King GL
    J Periodontol; 2008 Aug; 79(8 Suppl):1527-34. PubMed ID: 18673007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of innate and adaptive immunity in obesity-associated metabolic disease.
    McLaughlin T; Ackerman SE; Shen L; Engleman E
    J Clin Invest; 2017 Jan; 127(1):5-13. PubMed ID: 28045397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages and islet inflammation in type 2 diabetes.
    Eguchi K; Manabe I
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():152-8. PubMed ID: 24003932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, inflammation, and insulin resistance--a mini-review.
    Zeyda M; Stulnig TM
    Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance.
    Vandanmagsar B; Youm YH; Ravussin A; Galgani JE; Stadler K; Mynatt RL; Ravussin E; Stephens JM; Dixit VD
    Nat Med; 2011 Feb; 17(2):179-88. PubMed ID: 21217695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of NLRP3 inflammasome by γ-tocotrienol ameliorates type 2 diabetes.
    Kim Y; Wang W; Okla M; Kang I; Moreau R; Chung S
    J Lipid Res; 2016 Jan; 57(1):66-76. PubMed ID: 26628639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.
    Aroor AR; McKarns S; Demarco VG; Jia G; Sowers JR
    Metabolism; 2013 Nov; 62(11):1543-52. PubMed ID: 23932846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cells of innate and adaptive immunity in type 2 diabetes and obesity].
    Guzmán-Flores JM; López-Briones S
    Gac Med Mex; 2012; 148(4):381-9. PubMed ID: 22976756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression from high insulin resistance to type 2 diabetes does not entail additional visceral adipose tissue inflammation.
    Barbarroja N; Lopez-Pedrera C; Garrido-Sanchez L; Mayas MD; Oliva-Olivera W; Bernal-Lopez MR; El Bekay R; Tinahones FJ
    PLoS One; 2012; 7(10):e48155. PubMed ID: 23110196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance.
    O'Sullivan TE; Rapp M; Fan X; Weizman OE; Bhardwaj P; Adams NM; Walzer T; Dannenberg AJ; Sun JC
    Immunity; 2016 Aug; 45(2):428-41. PubMed ID: 27496734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose tissue inflammation and metabolic dysfunction: a clinical perspective.
    Tam CS; Redman LM
    Horm Mol Biol Clin Investig; 2013 Sep; 15(1):19-24. PubMed ID: 25436729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.